Startup profile · funding coverage
Heidi Health funding, valuation and investors
Clinical AI platform for documentation and health-system workflows.
Keep track of Heidi Health
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series C plus growth financing
$340M package · September 22, 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$340M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
growth · Melbourne, Australia
Overview
Heidi Health develops clinical AI assistants and agents used for documentation and other health-system workflows.
Why Heidi Health is interesting
Its financing combines conventional equity with a large customer-value-style growth facility, making the capital structure as important as the headline total.
Key facts
- Latest financing: $340M package (Series C plus growth financing)
Funding history (newest first)
Series C plus growth financing
2026-09-22 $340M packageSource: https://www.heidihealth.com/blog/heidi-secures-us340m-to-scale-agents-across-health-systems-globally
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Heidi Health's financing or category context.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.